Pittsburgh, PA, United States of America

Anthony Killian

This inventor holds 1 USPTO granted patent. Top assignee: Tap Holdings, LLC. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Killian. Retrieved from https://idiyas.com/inventor/anthony-killian-jugudkjt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anthony Killian

Introduction

Anthony Killian is a notable inventor based in Pittsburgh, PA (US). He has made significant strides in the field of medicine, particularly in the treatment of chronic obstructive pulmonary disease (COPD). His innovative approach has the potential to improve the quality of life for many individuals suffering from this debilitating condition.

Latest Patents

Anthony Killian holds a patent for a method of treating chronic obstructive pulmonary disease. The patent details a class of .OMEGA.-substituted-1,4-benzoquinon-2-yl]alkanoic acids that are useful in the treatment of COPD. The preferred compound for this method is 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid or a pharmaceutically acceptable salt, ester, or pro-drug thereof. This patent showcases his commitment to advancing medical treatments.

Career Highlights

Anthony is associated with Tap Holdings, LLC, where he applies his expertise in developing innovative solutions for health-related challenges. His work at the company reflects his dedication to improving patient outcomes through scientific research and development.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Anthony Killian's contributions to the field of medicine through his innovative patent demonstrate his commitment to addressing significant health issues. His work has the potential to make a lasting impact on the treatment of chronic obstructive pulmonary disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…